Introduction Hypertension (HTN) is prevalent in patients with systemic lupus erythematosus
(SLE) and causes early cardiovascular aging and progression of renal and cardiac disease …

Introduction It remains unclear how the presence of renal involvement will affect the
cardiovascular (CV) risk factors and complications in patients with SLE. Methods We …

Método: se realizó estudio descriptivo, prospectivo de casos y controles con pacientes con
diagnóstico de lupus eritematoso sistémico fueran atendidos en el Centro de Reumatología …

A comprehensive approach that includes cardiovascular risk factor modification, control of
systemic inflammation, and increased patient and physician awareness is needed in …

Abstract Background Patients with Systemic Lupus Erythematosus (SLE) have an increased
risk of metabolic syndrome (MS) and cardiovascular disease (CVD). MS is evaluated binary …

Цель исследования: изучить структурно-функционального состояния миокарда у
больных артериальной гипертензией (АГ) в сочетании с гастроэзофагеальной …

Objectives. To test whether non-fasting and fasting triglyceride (TG) levels differ in individual
patients and whether TG (non-fasting and fasting) levels predict coronary artery disease …

To evaluate the association of C-reactive protein (CRP) polymorphisms with risk of
development SLE in a group of Mexican individuals. Five CRP polymorphisms (rs3093059 …

Objectives Systemic lupus erythematosus (SLE) is associated with considerable
cardiovascular morbidity that has not yet been directly compared with other diseases with …

Statin therapy decreases cardiovascular morbidity and mortality rates when used as either
primary or secondary prevention. An immunomodulating effect of statins has been …